总时间（秒）：26134.37
问答时间（秒）：721.49

```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
```

The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
```

The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position": "46"
            },
            "Description in input context": "E46K"
        }
    ]
}
``` The provided text mentions the A30P, A53T, and E46K mutations in a-synuclein, which are associated with Parkinson's disease (PD) and promote a-synuclein aggregation in vitro.
Answer:
 
```json
{
    "Gene": "a-synuclein",
    "variants": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "P",
                "position": "30"
            },
            "Description in input context": "A30P"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "A",
                "alt": "T",
                "position": "53"
            },
            "Description in input context": "A53T"
        },
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "N.D.",
                "alt": "N.D.",
                "position": "N.D."
            },
            "Protein Change": {
                "ref": "E",
                "alt": "K",
                "position":